Molecular and neuronal substrate for the selective attenuation of anxiety

K. Low, F. Crestani, R. Keist, D. Benke, I. Brunig, J. A. Benson, J. M. Fritschy, T. Rulicke, H. Bluethmann, H. Mohler, U. Rudolph

Research output: Contribution to journalArticlepeer-review


Benzodiazepine tranquilizers are used in the treatment of anxiety disorders. To identify the molecular and neuronal target mediating the anxiolytic action of benzodiazepines, we generated and analyzed two mouse lines in which the α2 or α3 GABA(A) (γ-aminobutyric acid type A) receptors, respectively, were rendered insensitive to diazepam by a knock-in point mutation. The anxiolytic action of diazepam was absent in mice with the α2(H101R) point mutation but present in mice with the α3(H126R) point mutation. These findings indicate that the anxiolytic effect of benzodiazepine drugs is mediated by α2 GABA(A) receptors, which are largely expressed in the limbic system, but not by α3 GABA(A) receptors, which predominate in the reticular activating system.

Original languageEnglish (US)
Pages (from-to)131-134
Number of pages4
Issue number5489
StatePublished - Oct 6 2000
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Molecular and neuronal substrate for the selective attenuation of anxiety'. Together they form a unique fingerprint.

Cite this